查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1615412

基因表現分析市場：按產品、應用和最終用戶分類 - 2025-2030 年全球預測

Gene Expression Analysis Market by Offering (Instruments, Reagents & Consumables, Services), Application (Clinical Diagnostics, Drug Discovery & Development), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年，基因表現分析市值為 40 億美元，預計到 2024 年將達到 43 億美元，預計複合年成長率為 7.80%，到 2030 年將達到 67.7 億美元。

基因表現分析檢查基因在各種生物條件下的活性（表達），對於了解疾病、藥物交互作用和發育過程至關重要。他們的需求源於其在個人化醫療中的關鍵作用，幫助識別疾病標記和治療靶點，最終改善患者的治療結果。應用範圍涵蓋腫瘤學、藥物基因組學和農業生物技術，並用於實驗室、製藥公司和臨床診斷。精準醫療需求的不斷成長、測序技術的進步以及慢性病的增加推動了市場的成長。特別是，RNA-seq 和高通量微陣列技術的出現徹底改變了研究人員進行遺傳分析的方式，實現了更全面的資料收集和分析。

主要市場統計
基準年[2023] 40億美元
預測年份 [2024] 43億美元
預測年份 [2030] 67.7億美元
複合年成長率（%） 7.80%

然而，該市場受到先進平台的高成本和資料管理挑戰（例如處理巨量資料時儲存和解釋的複雜性）的限制。嚴格的法律規範也會減慢創新和採用率。然而，開發具有成本效益的快速診斷工具，將人工智慧和機器學習整合起來進行資料分析，從而提高速度和準確性，並存在潛在的機會。開發簡化資料解釋的應用程式還可以彌合資料生成和臨床應用之間的差距。這對於提高可推動個人化治療的大型資料集的效用尤其重要。

基因編輯技術與表達分析相結合以及專注於單細胞RNA測序等創新領域為未來的成長帶來了巨大的希望。此外，旨在透過基因表現見解提高作物抗性和產量的農業生物技術的新應用可能會使市場成長管道多樣化。研究機構和技術開發商之間的合作對於推動產業進步至關重要。儘管面臨挑戰，公司可以透過專注於這些創新前沿並透過強力的夥伴關係和研發投資來最佳化其技術採用策略，從而有效地利用未來的市場機會。

市場動態：快速發展的基因表現分析市場的關鍵市場洞察

供需的動態交互作用正在改變基因表現分析市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病增加
    • 人們越來越偏好基於基因的診斷
    • 基因編輯技術、定序和生物資訊學不斷進步
  • 市場限制因素
    • 技術純熟勞工短缺、設備及用品相關成本；
  • 市場機會
    • 日益關注精準腫瘤學
    • 對個體化醫療的需求不斷增加
  • 市場挑戰
    • 對資料解釋的擔憂

波特五力：駕馭基因表現表現分析市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因表現分析市場的外部影響

外部宏觀環境因素在塑造基因表現分析市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因表現分析市場的競爭狀況

基因表現分析市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因表現分析市場供應商績效評估

FPNV定位矩陣是評估基因表現分析市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製基因表現分析市場的成功之路

基因表現分析市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病流行
      • 人們對基於基因的診斷越來越感興趣
      • 基因編輯技術、定序和生物資訊學的進展
    • 抑制因素
      • 熟練勞動力的短缺以及與設備和用品相關的成本；
    • 機會
      • 精準腫瘤學受到越來越多的關注
      • 客製化醫療服務的需求不斷成長
    • 任務
      • 對資料解釋的擔憂
  • 市場區隔分析
    • 我們提供什麼：更多採用具有特異性和擴充性的先進設備
    • 應用：基因表現分析對於簡化藥物標靶辨識的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基因表現分析市場：透過提供

  • 裝置
    • 微陣列掃描儀
    • 次世代定序（NGS）平台
    • PCR
  • 試劑/耗材
    • 檢測方法和套件
    • DNA微陣列
    • 酵素
  • 服務

第7章基因表現分析市場：依應用分類

  • 臨床診斷
  • 藥物發現與開發

第 8 章基因表現分析市場：依最終用戶分類

  • 學術/研究機構
  • 診斷實驗室
  • 製藥和生物技術公司

第9章北美和南美基因表現分析市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區基因表現分析市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的基因表現分析市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Thermo Fisher Scientific 推出 Invitrogen TaqMan Cells-to-CT Express 試劑套件以簡化 RNA 處理。
    • Tempus 推出了 Tempus xR，獨立的 RNA定序測試。
    • QIAGEN 推出增強版 QIAGEN CLC Genomics Workbench Premium
  • 戰略分析和建議

公司名單

  • 10x Genomics
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • BioSpyder, Inc.
  • CD Genomics
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Inotiv, Inc.
  • LGC Limited
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • NanoString Technologies Inc.
  • New England Biolab
  • Oxford Gene Technology IP Limited
  • Oxford Nanopore Technologies plc
  • Promega Corporation
  • QIAGEN NV
  • Revvity, Inc.
  • Standard BioTools
  • Takara Bio, Inc.
  • Thermo Fisher Scientific Inc
  • Zymo Research Corporation
Product Code: MRR-EA11B604F62B

The Gene Expression Analysis Market was valued at USD 4.00 billion in 2023, expected to reach USD 4.30 billion in 2024, and is projected to grow at a CAGR of 7.80%, to USD 6.77 billion by 2030.

Gene expression analysis involves examining the activity (expression) of genes in various biological conditions, making it integral to understanding diseases, drug interactions, and development processes. Its necessity arises from its pivotal role in personalized medicine, where it aids in identifying disease markers and therapeutic targets, ultimately improving patient outcomes. Applications span across oncology, pharmacogenomics, and agricultural biotechnology, with usage in research laboratories, pharmaceutical companies, and clinical diagnostics. Market growth is driven by increased demand for precision medicine, advancements in sequencing technologies, and rising incidences of chronic diseases. Particularly, the advent of RNA-seq and high-throughput microarray technologies has revolutionized how researchers approach genetic analyses, allowing more comprehensive data collection and analysis.

KEY MARKET STATISTICS
Base Year [2023] USD 4.00 billion
Estimated Year [2024] USD 4.30 billion
Forecast Year [2030] USD 6.77 billion
CAGR (%) 7.80%

However, the market is fraught with limitations like high costs of advanced platforms and data management challenges, including storage and interpretation complexities in handling big data. Stringent regulatory frameworks can also slow innovation and adoption rates. Yet, potential opportunities exist in developing cost-effective, rapid diagnostic tools that integrate AI and machine learning for data analysis, improving both speed and accuracy. Developing applications that streamline and simplify data interpretation can also bridge gaps between data generation and clinical application. This is particularly crucial in increasing the utility of large datasets, which can drive personalized therapies.

Innovative areas such as integrating gene editing technologies with expression analysis or focusing on single-cell RNA sequencing hold substantial promise for growth. Furthermore, novel applications in agricultural biotech, aiming to enhance crop resistance and yield through gene expression insights, can diversify market growth channels. Collaboration between research entities and tech developers will be vital for propelling industry advancements. Despite challenges, focusing on these innovative fronts and optimizing technology adoption strategies through strong partnerships and investment in R&D can position businesses to harness upcoming market opportunities efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Expression Analysis Market

The Gene Expression Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases
    • Increasing preference for gene-based diagnostics
    • Growing advancements in gene editing technology, sequencing, and bioinformatics
  • Market Restraints
    • Lack of skilled labor and expenses associated with the instruments and consumables
  • Market Opportunities
    • Increasing focus on precision oncology
    • Rising need for customized medicine
  • Market Challenges
    • Concerns associated with the interpretation of data

Porter's Five Forces: A Strategic Tool for Navigating the Gene Expression Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Expression Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Expression Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Expression Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Expression Analysis Market

A detailed market share analysis in the Gene Expression Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Expression Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Expression Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Expression Analysis Market

A strategic analysis of the Gene Expression Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Expression Analysis Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSpyder, Inc., CD Genomics, Charles River Laboratories International, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Inotiv, Inc., LGC Limited, Merck KGaA, Meridian Bioscience, Inc., NanoString Technologies Inc., New England Biolab, Oxford Gene Technology IP Limited, Oxford Nanopore Technologies plc, Promega Corporation, QIAGEN N.V., Revvity, Inc., Standard BioTools, Takara Bio, Inc., Thermo Fisher Scientific Inc, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Expression Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Consumables, and Services. The Instruments is further studied across Microarray Scanners, Next-generation Sequencing (NGS) Platforms, and PCR. The Reagents & Consumables is further studied across Assays & Kits, DNA Microarray, and Enzymes.
  • Based on Application, market is studied across Clinical Diagnostics and Drug Discovery & Development.
  • Based on End-user, market is studied across Academic & Research Institutions, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases
      • 5.1.1.2. Increasing preference for gene-based diagnostics
      • 5.1.1.3. Growing advancements in gene editing technology, sequencing, and bioinformatics
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled labor and expenses associated with the instruments and consumables
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing focus on precision oncology
      • 5.1.3.2. Rising need for customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the interpretation of data
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Growing adoption of advanced instruments with specificity and scalability
    • 5.2.2. Application: Rising significance of gene expression analysis in streamlining the identification of drug targets
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Expression Analysis Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Microarray Scanners
    • 6.2.2. Next-generation Sequencing (NGS) Platforms
    • 6.2.3. PCR
  • 6.3. Reagents & Consumables
    • 6.3.1. Assays & Kits
    • 6.3.2. DNA Microarray
    • 6.3.3. Enzymes
  • 6.4. Services

7. Gene Expression Analysis Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Diagnostics
  • 7.3. Drug Discovery & Development

8. Gene Expression Analysis Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Diagnostic Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Gene Expression Analysis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Gene Expression Analysis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Gene Expression Analysis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Thermo Fisher Scientific Launched the Invitrogen TaqMan Cells-to-CT Express Kit for Streamlined RNA Processing
    • 12.3.2. Tempus launched Tempus xR, a standalone RNA Sequencing Test
    • 12.3.3. QIAGEN Launched Enhanced QIAGEN CLC Genomics Workbench Premium
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics
  • 2. Agilent Technologies Inc.
  • 3. Bio-Rad Laboratories Inc.
  • 4. BioSpyder, Inc.
  • 5. CD Genomics
  • 6. Charles River Laboratories International, Inc.
  • 7. Danaher Corporation
  • 8. DiaSorin S.p.A.
  • 9. Eurofins Scientific SE
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Illumina Inc.
  • 12. Inotiv, Inc.
  • 13. LGC Limited
  • 14. Merck KGaA
  • 15. Meridian Bioscience, Inc.
  • 16. NanoString Technologies Inc.
  • 17. New England Biolab
  • 18. Oxford Gene Technology IP Limited
  • 19. Oxford Nanopore Technologies plc
  • 20. Promega Corporation
  • 21. QIAGEN N.V.
  • 22. Revvity, Inc.
  • 23. Standard BioTools
  • 24. Takara Bio, Inc.
  • 25. Thermo Fisher Scientific Inc
  • 26. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GENE EXPRESSION ANALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. GENE EXPRESSION ANALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENE EXPRESSION ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE EXPRESSION ANALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE EXPRESSION ANALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. GENE EXPRESSION ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023